Medicine and Dentistry
Myeloid metaplasia
100%
Diagnosis
80%
Therapeutic Procedure
80%
Retrospective Study
60%
Leukemia
60%
Prospective Study
60%
Association
60%
Blood
60%
Overall Survival
40%
Hematinic
40%
Danazol
40%
Survival
40%
Patient
40%
Predictor
20%
Multivariate Analysis
20%
Combination Therapy
20%
Univariate Analysis
20%
Scoring System
20%
Hydroxyurea
20%
Evaluation Study
20%
Thalidomide
20%
Drug
20%
Chemotherapeutic Agent
20%
Indicator
20%
Nursing and Health Professions
Diagnosis
80%
Time
80%
Inpatient
80%
Overall Survival
40%
Platelet Count
40%
Antianemic Agent
40%
Survival
40%
Parameters
40%
Danazol
40%
Hospital
20%
Combination Therapy
20%
Multivariate Analysis
20%
Scoring System
20%
Univariate Analysis
20%
Leukocyte Count
20%
Hemoglobin Blood Level
20%
Thalidomide
20%
Hydroxyurea
20%
Drug
20%
Evaluation Study
20%
Symptom
20%
Indicator
20%
Contrast
20%
Monocyte Count
20%
Biochemistry, Genetics and Molecular Biology
Time
80%
Association
60%
Overall Survival
40%
Platelet Count
40%
Erythropoiesis-Stimulating Agents
40%
Danazol
40%
Survival
40%
Multivariate Analysis
40%
Mutation
20%
Hemoglobin Blood Level
20%
Contrast
20%
Leukocyte Count
20%
Monocyte Count
20%
Pharmacology, Toxicology and Pharmaceutical Science
Myeloid metaplasia
100%
Overall Survival
40%
Danazol
40%
Antianemic Agent
40%
Survival
40%
Hydroxycarbamide
20%
Indicator
20%
Drug
20%
Thalidomide
20%
Symptom
20%
Psychology
Treatment
80%
Evaluation
20%
Multivariate Model
20%
Univariate Statistics
20%